Publications by authors named "J Hugon"

Claim this Profile
C
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.
Clément Aveneau, Elodie Lamy, Stanislas Grassin-Delyle, Marta Sanchez-Ortiz, Eric Vicaut, Jacques Hugon

J Alzheimers Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid.
Elodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, Matthieu Martinet, Claire Hourregue, Jacques Hugon

Clin Chem Lab Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of physical activity on cognitive function in patients with neurocognitive disorders: A systematic review.
Théodore Decaix, Claire Bonnin, Karl Götze, Véronique François, Camille Petit, Jacques Hugon

J Frailty Aging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau seeding activity in the cerebrospinal fluid of Alzheimer disease patients predicts short-term cognitive decline.
Ludivine Houzé, Marc Dhenain, Suzanne Lam, Fanny Petit, Stéphane Haïk, Jacques Hugon

Alzheimers Res Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual risk of anticholinergic burden and CSF alzheimer's biomarkers in older patients: a mortality follow-up study from daily medical practice.
Théodore Decaix, Julien Dumurgier, Emmanuel Cognat, Karl Götze, François Mouton-Liger, Jacques Hugon

Alzheimers Res Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis